Jyoti Kumar, M.D., M.S.

Jyoti Kumar, M.D., pathologist with Clinical Pathology Associates
Sub-Specialties
HematopathologyMolecular

Joined Clinical Pathology Associates: 2024

Primary Service Location:

Rotating sites

Board Certifications:

  • Anatomic and Clinical Pathology (2020)
  • Hematopathology (2021)
  • Molecular Genetic Pathology (2022)

Fellowships:

  • Molecular Genetic Pathology, Stanford University
  • Hematopathology, Stanford University

Residency:

  • Stanford University (AP/CP)
  • Baylor College of Medicine (AP/CP)

Medical School:

  • Ross University School of Medicine

Undergraduate Education:

  • Cornell University

Additional Education:

  • Rutgers University – Master of Science: Biomedical Sciences

Selected Publications:

  • Kumar J, Lewis NE, Londono D, Sun X, Gao Q, Arcila ME, Roshal M, Zhang Y, Xiao W, Chan A. Diagnostic challenges and proposed classification of myeloid neoplasms with overlapping features of thrombocytosis, ring sideroblasts and concurrent del(5q) and SF3B1 mutations. Haematologica. 2024;109(8):2676-2681. PMID: 38572547.
  • Kumar J, Ewalt MD, Zhang Y, Yao J, Thompson MC, Dogan A. Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukemia. Br J Haematol. 2024;204(2):561-565. PMID: 38031233.
  • Khanna V, Lu R, Kumar J, Molina A, Stehr H, Spiteri E, Spinner M, Silva O, Fernandez-Pol S, Tan B, Greenberg PL. The Clinical, Molecular, and Prognostic Features of the 2022 WHO and ICC Classification Systems for Myelodysplastic Neoplasms. Leuk Res. 2024;136:107433. PMID: 38154193.
  • Kumar J, Petrova-Drus K. Acute leukemia with predominantly myeloid differentiation and TBL1XR1::CSF1R fusion. Blood. 2023;142(14):1253. PMID: 37796515.
  • Kumar J, Patel S, Chang A, Mukherjee S, Small C, Gollapudi S, Butzmann A, Jangam D, Weinberg OK, George TI, Zehnder JL, Ohgami RS. Smoking status in acute myeloid leukemia is associated with worse overall survival and independent of prior non-hematopoietic malignancies, cytogenetic abnormalities, and WHO category. Hum Pathol. 2023;135:45-53. PMID: 36921727.
  • Testa S, Kumar J, Goodell AJ, Zehnder JL, Alexander KM, Sidana S, Arai S, Witteles RM, Liedtke M. Prevalence, Mutational Spectrum and Clinical Implications of Clonal Hematopoiesis of Indeterminate Potential in Plasma Cell Dyscrasias. Semin Oncol. 2022;49(6):465-475. PMID: 36503855.
  • Kumar J, Alspach AE, Zucker JP, Gratzinger DA. Systemic presentation of somatic TET2 mutated B-cell lymphoma in a child with Kabuki syndrome and germline KMT2D variant. Am J Clin Pathol. 2022;158(5):564-569. PMID: 36048893.
  • Kumar J, Al-Kawaaz M, Martin BA, Hegazi MM, Tan B, Gratzinger DA. Histiocytic sarcoma with CCND1 gene rearrangement clonally related and transdifferentiated from mantle cell lymphoma. Am J Clin Pathol. 2022;158(4):449-455.  PMID: 35964234.
  • Scott GD, Kumar J, Oak JS, Boyd SD, Raess PW, Gratzinger DA. Histology-Independent Signature Distinguishes Kikuchi-Fujimoto Disease/Systemic Lupus Erythematosus-Associated Lymphadenitis From Benign and Malignant Lymphadenopathies. Am J Clin Pathol. 2020;154(2):215-224.  PMID: 32367142.
  • Kumar J, Butzmann A, Wu S, Easly S, Zehnder JL, Warnke RA, Bangs CD, Jangam D, Cherry A, Lau J, Nybakken G, Ohgami RS. Indolent In Situ B-Cell Neoplasms With MYC Rearrangements Show Somatic Mutations in MYC and TNFRSF14 by Next-generation Sequencing. Am J Surg Pathol. 2019;43(12):1720-1725. PMID: 31368914.